Clinical trial Recruiting at 1 site Observational Ages 6 Months and up

Analyzing blood samples for pediatric solid tumors

Official title: Liquid Biopsies in Non-CNS Malignant Pediatric Solid Tumors

Run by Children's Hospital Los Angeles · NCT05068583 · Data updated 2026-11-12

This study is trying to see if blood tests can help track how well treatment is working for kids with solid tumors by looking for cancer-related material in their blood.

Quick facts

Study typeObservational
Ages6 Months and up
SexAll
Enrollment320 (estimated)
SponsorChildren's Hospital Los Angeles
Academic / other
Locations1 site (Los Angeles, California)
StatusRecruiting
StartedMay 8, 2019
Main results expectedMay 8, 2029
Study endsMay 8, 2034
Registry record updatedAugust 21, 2024
Trial IDNCT05068583 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include children aged 6 months to 21 years with newly diagnosed or relapsed/refractory high-grade solid tumors.

Probably not a fit

Patients with CNS malignancies or those under 6 months of age may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to determine the feasibility of detecting tumor-derived material in the blood of pediatric patients with solid tumors. By collecting serial blood samples from patients at various stages of treatment, including before, during, and after therapy, the study will analyze cell-free DNA, RNA, and other tumor-related substances. The findings will be correlated with traditional disease evaluation methods to assess the effectiveness of liquid biopsies in monitoring disease progression and treatment response.

Why it matters

Potential benefit: If successful, this study could provide a non-invasive method for monitoring pediatric solid tumors, improving disease management and patient outcomes.

How similar studies have gone: While liquid biopsies have shown promise in adult cancers, their application in pediatric solid tumors is still being explored, making this approach relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Newly diagnosed, relapsed, or refractory histologically confirmed high grade bone or soft tissue sarcoma or malignant renal, thyroid, germ cell, or hepatic tumors, OR
* Healthy individual with no history of cancer or chronic medical problems and \< 21 years of age

Exclusion Criteria:

* CNS Malignancies
* Individuals \< 6 months of age

Where it's running

  • Children's Hospital Los Angeles
    Los Angeles, California, United States
    Recruiting

Study contacts

  • Principal investigator: Fariba Navid, MD — Children's Hospital Los Angeles
  • Study coordinator: Fariba Navid, MD
  • Email: fnavid@chla.usc.edu
  • Phone: 323-361-2529

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.